Contact the MHRA

AI Summary

This document provides a comprehensive contact directory for the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA). It is designed to assist stakeholders in navigating the UK’s regulatory framework for medicines and medical devices by identifying the correct departments for specific enquiries, thereby improving response times. The guide covers a wide range of regulatory activities, including marketing authorizations, pharmacovigilance procedures, clinical trial submissions, and manufacturer licensing. While the provided text is a navigational guide rather than an enforcement report—and thus does not list specific inspection dates or violations—it outlines the required actions for entities seeking to remain compliant with UK law. Specifically, stakeholders are directed to use dedicated email addresses and portals for various tasks, such as reporting defective products through the Defective Medicines Reporting Centre (DMRC) or submitting suspected side effects via the Yellow Card Scheme. Additionally, the document provides specialized contact information for whistleblowers and reports of illegal dealings or falsified medicines. By following these established communication channels, companies ensure that their applications for licenses, variations, and safety reports are handled by the appropriate regulatory experts. The MHRA emphasizes that using these specific contacts is essential for the efficient processing of regulatory submissions and maintaining compliance within the UK healthcare market.